SCHEMBL2213588

SCHEMBL2213588

C[C@@H]1CN(c2cnc(-c3nc4ccccc4s3)cc2C=O)C[C@H](C)O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.41
ALDH1A1 P00352 8/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 7/20 0.40
GAA P10253 2/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 2/20 0.39
PKM P14618 1/20 0.39
HSD17B10 Q99714 4/20 0.37
TSHR P16473 3/20 0.37
MAPK1 P28482 2/20 0.37
KCNH2 Q12809 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
NPSR1 Q6W5P4 4/20 0.37
LMNA P02545 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2213608 0.82 KDM4E (0.43) ALDH1A1HPGDKDM4EGAAMEN1
SCHEMBL2215437 0.81 HSD17B10 (0.43) IRAK4ALDH1A1HPGDKDM4EGAA
SCHEMBL2213110 0.80 ALDH1A1 (0.42) IRAK4ALDH1A1HPGDKDM4EGAA
SCHEMBL2213094 0.78 PIK3CA (0.41) ALDH1A1KDM4EGAAKMT2ARAB9A
SCHEMBL2214499 0.78 HTT (0.38) ALDH1A1HPGDKDM4EGAAMEN1
SCHEMBL2214659 0.76 NPC1 (0.41) ALDH1A1HPGDKDM4EGAAMEN1
SCHEMBL2213684 0.75 CYP2A6 (0.42) KDM4EKMT2ARAB9AMAPTTDP1
SCHEMBL2212210 0.75 KDM4E (0.41) ALDH1A1HPGDKDM4EGAAKMT2A
SCHEMBL2215831 0.75 KDM4E (0.40) ALDH1A1KDM4EGAAKMT2ARAB9A
SCHEMBL2213101 0.74 KMT2A (0.40) ALDH1A1KDM4EGAAKMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178064-A1 SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL ASTRAZENECA R&D (SE) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178064-A1 SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL TBCA, TUBA1A, BROX IRAK4 2276/4885ALDH1A1 246/4885HPGD 292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.